1795 Meishih Announces Board Approval to Increase Capital in Singapore Subsidiary Lotus International Pte. Ltd.
AI Summary (NQ-processed)
Meishih announced that its board has approved a capital increase of USD 20 million in its 100%-owned Singapore subsidiary, Lotus International Pte. Ltd., to strengthen product portfolio and operational funding.
AI Analysis
Frequently Asked Questions
Q: What kind of company is Meishih?
A: A Taiwan-based pharmaceutical company specializing in drug and healthcare product development.
Q: How much is the capital increase?
A: USD 20 million, priced at USD 1 per share, totaling NTD 632.8 million.
Q: How will the funds be sourced?
A: Entirely from internal funds, with no external borrowing involved.
Q: What is the name of the subsidiary?
A: Lotus International Pte. Ltd., headquartered in Singapore.
Q: What is the purpose of this investment?
A: To strengthen the product portfolio and supplement the subsidiary’s operational capital.